GoodRx Inc. (GDRX)
4.42
-0.08 (-1.78%)
At close: Mar 31, 2025, 3:59 PM
4.41
-0.34%
After-hours: Mar 31, 2025, 04:06 PM EDT
GoodRx Cash Flow Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Net Income | 16.39M | -8.87M | -32.83M | -25.25M | -293.62M | 66.05M | 43.79M |
Depreciation & Amortization | n/a | 111.77M | 54.18M | 34.54M | 18.43M | 13.57M | 9.81M |
Stock-Based Compensation | n/a | 104.82M | 120.23M | 160.46M | 397.29M | 3.75M | 1.76M |
Other Working Capital | n/a | -12.93M | -20.79M | 27.95M | 2.88M | 168K | 2.96M |
Other Non-Cash Items | -16.23M | 18.07M | 25.98M | 7.98M | 52.62M | 10.41M | 4.1M |
Deferred Income Tax | n/a | -65.56M | -497K | 12.85M | -10.91M | -5.67M | -2.43M |
Change in Working Capital | n/a | -21.94M | -20.29M | -11.8M | -32.46M | -4.82M | -11.77M |
Operating Cash Flow | 163K | 138.29M | 146.78M | 178.78M | 131.34M | 83.29M | 45.25M |
Capital Expenditures | n/a | -55.77M | -55.21M | -34.46M | -35.82M | -5.75M | -3.46M |
Acquisitions | n/a | n/a | -155.28M | -144.28M | -55.79M | -31.31M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -70.35M | -54.72M | -34.67M | -29.89M | -15.27M | -4.32M | -2.65M |
Investing Cash Flow | -70.35M | -55.77M | -210.5M | -178.73M | -91.62M | -37.05M | -3.46M |
Debt Repayment | -167M | -5.27M | -7.03M | -7.03M | -7.03M | -57.23M | 606.88M |
Common Stock Repurchased | -158.84M | -103.97M | -101.72M | -57.69M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -1.35B |
Other Financial Acitivies | -11.64M | -58.15M | -11.48M | -23.5M | -78.95M | 828K | 1.45B |
Financial Cash Flow | -337.5M | -167.4M | -120.23M | -30.53M | 905.82M | -54.78M | -24.73M |
Net Cash Flow | -223.95M | -84.87M | -183.94M | -30.48M | 945.54M | -8.55M | 17.06M |
Free Cash Flow | 163K | 82.53M | 91.57M | 144.32M | 95.52M | 77.54M | 41.8M |